Abstract:A 40-year-old male patient was referred to our department with complains of recurrent oral ulcer for more than 20 years and vulvar ulcer for more than 10 years. He presented with a 3-month history of right external ophthalmoplegia. More than 10 days ago, the patient received ganglioside infusion. And one week ago, he developed numbness and pain of his lambs, and progressive myasthenia, accompanied by right blepharoptosis and dysuria. On exam, motor strength was graded 0/5 in the lower and the upper extremities. Deep tendon reflexes were diminished in extremities. His admission medical examination: hemoglobin (HGB), white cell and platelet counts were normal. C-reactive protein (CRP) was negative. Erythrocyte sedimentation rate (ESR) 53 mm/h. Antinuclear antibody (ANA), anti-dsDNA antibody, anti-Smith antibody, anti-cardiolipin antibody and human leucocyte antigen B51 were all within normal range. The etiological tests of influenza A pathogen, influenza B pathogen, parainfluenza virus, enterovirus and parvovirus were all negative. He tested positive for serum anti-GM1 IgG. Cerebrospinal fluid had a normal white cell count, an elevated protein content. Gram staining, culture and PCR detection for varicella-zoster virus, cytomegalovirus and herpes simplex virus were all negative. Antibodies associated with autoimmune encephalitis and paraneoplastic syndrome were negative in cerebrospinal fluid. Electromyography and nerve conduction studies showed a severe axonal damage affecting motor nerves. No obvious abnormalities were observed in his magnetic resonance imaging of brain and cavernous sinus. The patient was diagnosed with Behcet syndrome complicated with acute Guillain-Barré syndrome. He received intravenous methylprednisolone, intravenous immunoglobulin (IVIg) therapy, plasma exchange and rituximab treatment. After treatment, the patient's muscle strength of limbs was restored to grade 1, blepharoptosis and pain disappeared. The nervous system involvement of Behcet syndrome is relatively rare, especially combined with Guillain-Barré syndrome, which is easy to cause misdiagnosis. The treatment of Behcet syndrome complicated with acute Guillain-Barré syndrome includes the treatment of primary disease, plasma exchange and IVIg therapy. In addition, supportive treatment is very important for such patients. The focus of treatment is to avoid respiratory insufficiency, prevent deep vein thrombosis, monitor cardiac function and hemodynamics. Pain-relieving, physical exercise and psychological support are often under-recognized. The rehabilitation treatment is very important to improve the prognosis and quality of life of patients. What we need to learn is that when the symptoms and signs of the nervous system are difficult to be explained by neuro-Behcet syndrome alone, we should be alert to the possibility of other nervous system diseases.

Clinical manifestations, serology and epidemiology of Guillain-Barré syndrome.

Guillain-Barré Syndrome in a Boy with Lung Fluke Infection

Guillain-Barré syndrome in southern China: retrospective analysis of hospitalised patients from 14 provinces in the area south of the Huaihe River.

Changes of serum levels of neopterin in patients with Guillain-Barre syndrome

Clinical features and validation of Brighton criteria in Guillain-Barré syndrome in southern China:retrospective analysis of 1358 hospitalized patients in four years

Guillain-Barre Syndrome Caused by Hepatitis E Infection: Case Report and Literature Review

Limits of echography in the evaluation of ovarian tumors.

The analysis of misdiagnosis and mismanagement of 145 patients with Guillain-Barré syndrome in the emergency department

Clinical Analysis of 48 Cases with Guillain-Barré Syndrome

Building a framework for nursing research in cancer care.

Guillain-Barré syndrome in a 63-year-old patient possibly triggered by ehrlichiosis. Case report

Guillain‐Barré syndrome: A comprehensive review

Expanding our understanding of Guillain–Barré syndrome: Recent advances and clinical implications

Acute polyradiculoneuritis: Guillain-Barré syndrome

The effect of a new beta2-adrenoceptor agonist, salmefamol, on pentagastrin-induced gastric acid secretion in conscious dogs [proceedings].

Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome

Guillain-Barré syndrome: immunopathogenesis and therapeutic targets

A review of European research on consumer response to nutrition information on food labels

An audit on the clinical and laboratory profile of patients with different variants of Guillain-Barre syndrome and effect of various treatment strategies on their recovery

Co-existence of Guillain-Barré Syndrome and Behcet Syndrome: A Case Report

Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome